Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration
Abstract Tuberculosis (TB) treatment is long and complex, typically involving a combination of drugs taken for 6 months. Improved drug regimens to shorten and simplify treatment are urgently required, however a major challenge to TB drug development is the lack of predictive pre-clinical tools. To a...
Guardado en:
Autores principales: | Ghaith Aljayyoussi, Victoria A. Jenkins, Raman Sharma, Alison Ardrey, Samantha Donnellan, Stephen A. Ward, Giancarlo A. Biagini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eeb7497b0cef443d825c81af2749fe7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
por: Jinhai Wang, et al.
Publicado: (2021) -
The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
por: Andrzej Czyrski, et al.
Publicado: (2021) -
Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Jarosław Ruczyński, et al.
Publicado: (2019) -
Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors
por: Persson PB
Publicado: (2015) -
Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto K, et al.
Publicado: (2016)